Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and method for the treatment of x-linked centronuclear myopathy

Compositions and method for the treatment of x-linked centronuclear myopathy

US Patent 11666628 · Granted Jun 6, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dynamin 2 inhibitor for the treatment of centronuclear myopathies2022
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2022
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy2020
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2020
Dynamin 2 inhibitor for the treatment of centronuclear myopathies2020
Tyrosine-phosphatase-related protein2001